Director Charles Elliott Sigal buys 1,600 shares of Alnylam Pharmaceuticals ($ALNY) at $152.25

Director Charles Elliott Sigal bought 1,600 shares of Alnylam Pharmaceuticals at $152.25 per share, totaling $243,600. The open-market purchase was not under a 10b5-1 plan. Sigal now holds 3,600 shares indirectly through Sigal Family Investments, LLC.